561 related articles for article (PubMed ID: 14622273)
1. Aromatic amino-acid residues at the active and peripheral anionic sites control the binding of E2020 (Aricept) to cholinesterases.
Saxena A; Fedorko JM; Vinayaka CR; Medhekar R; Radić Z; Taylor P; Lockridge O; Doctor BP
Eur J Biochem; 2003 Nov; 270(22):4447-58. PubMed ID: 14622273
[TBL] [Abstract][Full Text] [Related]
2. Structure of acetylcholinesterase complexed with E2020 (Aricept): implications for the design of new anti-Alzheimer drugs.
Kryger G; Silman I; Sussman JL
Structure; 1999 Mar; 7(3):297-307. PubMed ID: 10368299
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the binding site of 1-benzyl-4-[(5,6-dimethoxy-1-indanon-2-yl)methyl]piperidine in acetylcholinesterase by docking studies with the SYSDOC program.
Pang YP; Kozikowski AP
J Comput Aided Mol Des; 1994 Dec; 8(6):683-93. PubMed ID: 7738604
[TBL] [Abstract][Full Text] [Related]
4. Differences in active-site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Chem Biol Interact; 1999 May; 119-120():61-9. PubMed ID: 10421439
[TBL] [Abstract][Full Text] [Related]
5. Does "butyrylization" of acetylcholinesterase through substitution of the six divergent aromatic amino acids in the active center gorge generate an enzyme mimic of butyrylcholinesterase?
Kaplan D; Ordentlich A; Barak D; Ariel N; Kronman C; Velan B; Shafferman A
Biochemistry; 2001 Jun; 40(25):7433-45. PubMed ID: 11412096
[TBL] [Abstract][Full Text] [Related]
6. Three-dimensional structure of a complex of E2020 with acetylcholinesterase from Torpedo californica.
Kryger G; Silman I; Sussman JL
J Physiol Paris; 1998; 92(3-4):191-4. PubMed ID: 9789806
[TBL] [Abstract][Full Text] [Related]
7. Dynamic mechanism of E2020 binding to acetylcholinesterase: a steered molecular dynamics simulation.
Niu C; Xu Y; Xu Y; Luo X; Duan W; Silman I; Sussman JL; Zhu W; Chen K; Shen J; Jiang H
J Phys Chem B; 2005 Dec; 109(49):23730-8. PubMed ID: 16375354
[TBL] [Abstract][Full Text] [Related]
8. Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).
Nochi S; Asakawa N; Sato T
Biol Pharm Bull; 1995 Aug; 18(8):1145-7. PubMed ID: 8535413
[TBL] [Abstract][Full Text] [Related]
9. Amino acid residues involved in the interaction of acetylcholinesterase and butyrylcholinesterase with the carbamates Ro 02-0683 and bambuterol, and with terbutaline.
Kovarik Z; Radić Z; Grgas B; Skrinjarić-Spoljar M; Reiner E; Simeon-Rudolf V
Biochim Biophys Acta; 1999 Aug; 1433(1-2):261-71. PubMed ID: 10446376
[TBL] [Abstract][Full Text] [Related]
10. Reversible inhibition of acetylcholinesterase and butyrylcholinesterase by 4,4'-bipyridine and by a coumarin derivative.
Simeon-Rudolf V; Kovarik Z; Radić Z; Reiner E
Chem Biol Interact; 1999 May; 119-120():119-28. PubMed ID: 10421445
[TBL] [Abstract][Full Text] [Related]
11. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
[TBL] [Abstract][Full Text] [Related]
12. Amino acid residues involved in stereoselective inhibition of cholinesterases with bambuterol.
Bosak A; Gazić I; Vinković V; Kovarik Z
Arch Biochem Biophys; 2008 Mar; 471(1):72-6. PubMed ID: 18167304
[TBL] [Abstract][Full Text] [Related]
13. The simulated binding of (+/-)-2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]meth yl] -1H-inden-1-one hydrochloride (E2020) and related inhibitors to free and acylated acetylcholinesterases and corresponding structure-activity analyses.
Inoue A; Kawai T; Wakita M; Iimura Y; Sugimoto H; Kawakami Y
J Med Chem; 1996 Oct; 39(22):4460-70. PubMed ID: 8893840
[TBL] [Abstract][Full Text] [Related]
14. 7-MEOTA-donepezil like compounds as cholinesterase inhibitors: Synthesis, pharmacological evaluation, molecular modeling and QSAR studies.
Korabecny J; Dolezal R; Cabelova P; Horova A; Hruba E; Ricny J; Sedlacek L; Nepovimova E; Spilovska K; Andrs M; Musilek K; Opletalova V; Sepsova V; Ripova D; Kuca K
Eur J Med Chem; 2014 Jul; 82():426-38. PubMed ID: 24929293
[TBL] [Abstract][Full Text] [Related]
15. Acetylcholinesterase active centre and gorge conformations analysed by combinatorial mutations and enantiomeric phosphonates.
Kovarik Z; Radić Z; Berman HA; Simeon-Rudolf V; Reiner E; Taylor P
Biochem J; 2003 Jul; 373(Pt 1):33-40. PubMed ID: 12665427
[TBL] [Abstract][Full Text] [Related]
16. Identification of amino acid residues involved in the binding of Huperzine A to cholinesterases.
Saxena A; Qian N; Kovach IM; Kozikowski AP; Pang YP; Vellom DC; Radić Z; Quinn D; Taylor P; Doctor BP
Protein Sci; 1994 Oct; 3(10):1770-8. PubMed ID: 7849595
[TBL] [Abstract][Full Text] [Related]
17. Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.
Saxena A; Redman AM; Jiang X; Lockridge O; Doctor BP
Biochemistry; 1997 Dec; 36(48):14642-51. PubMed ID: 9398183
[TBL] [Abstract][Full Text] [Related]
18. Novel donepezil-based inhibitors of acetyl- and butyrylcholinesterase and acetylcholinesterase-induced beta-amyloid aggregation.
Camps P; Formosa X; Galdeano C; Gómez T; Muñoz-Torrero D; Scarpellini M; Viayna E; Badia A; Clos MV; Camins A; Pallàs M; Bartolini M; Mancini F; Andrisano V; Estelrich J; Lizondo M; Bidon-Chanal A; Luque FJ
J Med Chem; 2008 Jun; 51(12):3588-98. PubMed ID: 18517184
[TBL] [Abstract][Full Text] [Related]
19. Structural aspects of 4-aminoquinolines as reversible inhibitors of human acetylcholinesterase and butyrylcholinesterase.
Bosak A; Opsenica DM; Šinko G; Zlatar M; Kovarik Z
Chem Biol Interact; 2019 Aug; 308():101-109. PubMed ID: 31100281
[TBL] [Abstract][Full Text] [Related]
20. The rationale for E2020 as a potent acetylcholinesterase inhibitor.
Kawakami Y; Inoue A; Kawai T; Wakita M; Sugimoto H; Hopfinger AJ
Bioorg Med Chem; 1996 Sep; 4(9):1429-46. PubMed ID: 8894101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
